Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
06.01.26
/
50%
€39.40
Target price
06.01.27
€68.23
Performance (%)
-16.75%
Price
17.03.26
€32.80
Summary
This prediction is currently active. The prediction for Crinetics Pharmaceuticals Inc disappoints with a performance of -16.75%. This prediction currently runs until 06.01.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 1.863% | 1.863% |
| iShares Core DAX® | -0.437% | -5.315% |
| iShares Nasdaq 100 | -0.194% | 3.078% |
| iShares Nikkei 225® | -0.951% | -5.884% |
| iShares S&P 500 | -0.420% | 0.922% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $77.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€37.40
29.09.25
29.09.25
€65.69
29.09.26
29.09.26
-12.30%
17.03.26
17.03.26
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€64.64
23.05.25
23.05.25
-42.86%
24.05.25
24.05.25